Company intelligence / Profile preview

Nestiva

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Nestiva is a biotechnology company dedicated to developing transformative therapies for neurodegenerative disorders, with a primary focus on Parkinson's disease. The company leverages deep expertise in small molecule drug discovery to target key genetic drivers of disease progression, such as LRRK2 and GBA. By focusing on precision medicine approaches, Nestiva aims to deliver disease-modifying treatments that address the underlying biological causes of neuronal loss. The company's leadership team consists of industry veterans with extensive experience in CNS drug development and commercialization.

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Nestiva.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nestiva.

Explore the full profile